CONTINUING OUR WEEKLY INVESTOR FOCUS: KEEPING TABS ON THE ACTIVE PLAYERS
Each week, we keep our eyes peeled for investment announcements, to keep tabs on investors we’ve already profiled into our website, as well as searching for new investors whom we haven’t previously featured.
This allows us to keep a dynamic database of active investors for SMEs to investigate, to find the most relevant ones, if they are on the equity capital raising trail.
So, if you want to check how your company’s investment proposition measures up against the 1000+ investors (and growing weekly) now profiled into our site, then visit https://www.matchcapitaluk.com/sign-up if it’s your first visit, or https://www.matchcapitaluk.com/login if you’re returning for a fresh look.
Apposite Capital is an independent investment firm focused exclusively on Healthcare. The firm operates at the small end of the private equity market, providing both capital and expertise to those businesses offering ‘disruptive’ models that aim to improve or reduce the cost of care provision and which have the potential of becoming market leaders. Apposite has an in-depth sector knowledge covering key aspects of the healthcare industry internationally coupled with local insights, an exceptional network and an entrepreneurial mindset which it applies to drive the growth of its portfolio companies. Apposite was created in 2006 and is headquartered in London, UK.
In May 2016, they made a £12M Venture Round investment into a company called Medical Imaging Partnership (read the full story here http://www.finsmes.com/2016/05/medical-imaging-partnership-receives-up-to-12m-investment-from-apposite-capital.html)
Mercia Technologies is one of the leading investment businesses in UK technology, specialising in the commercialisation of pioneering businesses across exciting growth sectors in which deep expertise is held. Mercia’s vision is to become a leading national player in the creation, funding, incubation and development of high-growth technology businesses with an emphasis in the Midlands and the North of the UK. Mercia brings together technology transfer, company formation and incubation, commercialisation and investment, to technology ventures across some of the highest growth sectors of the UK including:
• electronics and hardware;
• advanced materials, engineering and specialised manufacturing; and
• life sciences.
In May 2016, they invested £400,000 in Concepta Diagnostics (read the full story here http://www.lse.co.uk/AllNews.asp?code=q31n0eep&headline=Mercia_Technologies_Invests_GBP400000_In_Concepta_Diagnostics)
NVM Private Equity LLP (NVM) is independently owned with nearly 30 years experience of investing in unquoted UK businesses. NVM is a generalist investor, managing £290 million of funds, and is differentiated by having executives living and working in regional business communities throughout the UK. NVM seeks investment opportunities in UK businesses which have the right mix of growth potential and market vision. They may be looking to grow organically, acquire another business or secure a management buy-out. Typically, NVM looks to invest between £2 million and £10 million in each transaction.
In May 2016, NVM invested £2.5m in software business MPD (read full story here http://realdeals.eu.com/article/50783)
Maven Capital Partners is a leading VCT, Private Equity and Property Fund Manager, providing growth capital to UK SMEs and tax-efficient investment opportunities for investors. Maven manages over £400m of assets for a variety of client funds, including Venture Capital Trusts, the Scottish Loan Fund, the Greater Manchester Loan Fund and a syndicate of Investor Partners including a number of family offices and high net worth individuals. Maven has also assembled a highly experienced property team, with access to many interesting projects across the UK, often introduced to them off-market, and a collective expertise in development, asset management and financial structuring in the property sector. They offer a range of opportunities to investors who are looking for well-researched UK property deals, which have been thoroughly screened, to ensure that downside risk is minimised, and offer attractive risk-adjusted returns. The business is headquartered in Glasgow, and with five other offices throughout the UK.
In May 2016, Maven completed a £2.5m investment in The GP Service, a provider of online services for general medical consultations and prescriptions (read the full story here http://www.mavencp.com/about/latest/410-maven-invests-in-innovative-new-online-gp-service)